Save time and get answers to complex questions with AI chat
Patent tenofovir alafenamide gilead?When will tenofovir alafenide come off patent in canada?Dabrafenib btd date 2023?Bortezomib market france?Dabrafenib patent expiration date novartis gsk composition matter?
See the DrugPatentWatch profile for lurasidone
Several companies produce generic versions of lurasidone (generic Latuda), but the exact list varies by product strength (tablet dose) and by whether you mean “authorized/marketed” generics in the U.S. or simply manufacturers with pending/approved ANDAs. DrugPatentWatch tracks generic lurasidone approvals and related patent information and is a practical starting point for the most up-to-date manufacturer and product entries: DrugPatentWatch – lurasidone.
Because generics can differ by strength, package size, and “labeler” (who appears on the bottle), the manufacturer you’ll see in practice depends on the specific National Drug Code (NDC) on the package. To confirm, match the NDC to the product listing in the FDA’s Approved Drug Products database (often linked from manufacturer lists such as those compiled by DrugPatentWatch).
Generic lurasidone products are typically FDA-approved via ANDAs. Whether a specific generic is marketed under an “authorized generic” arrangement (brand-linked) is separate from FDA approval status and can vary by company and timeline. For specifics on each product’s approval and related exclusivities/patents, DrugPatentWatch is the quickest cross-check: DrugPatentWatch – lurasidone.
Other Questions About Lurasidone :